Clinical Trials in Salt Lake City

Showing 3501-3520 of 14,325 trials

QTX3046 in Patients With KRAS G12D Mutations

NCT06428500

Phase 1 study to determine the safety and tolerability of QTX3046 as a single agent or in combination with cetuximab.

Quanta Therapeutics240 participantsStarted May 2024

Grand Rapids, Michigan, United States • Durham, North Carolina, United States • Houston, Texas, United States +2 more locations

Active Not Recruiting< 1 mile

PaTH Clinical Data Research Network (CDRN) Idiopathic Pulmonary Fibrosis (IPF) Clinician Patient Partnership Cohort

NCT02407431

The purpose of the PaTH Network IPF Clinician-Patient Partnership Cohort is to use clinical data from electronic health records (EHR) and patient reported outcomes (PRO) to answer questions of clinical importance to patients with Idiopathic Pulmonary Fibrosis, providers, and other stakeholders.

Idiopathic Pulmonary Fibrosis

University of Pittsburgh1,000 participantsStarted Mar 2015

Baltimore, Maryland, United States • Hershey, Pennsylvania, United States • Philadelphia, Pennsylvania, United States +2 more locations

COMPLETEDPhase 3< 1 mile

SI-6603 (Condoliase) Study for Lumbar Disc Herniation (Discovery 6603 Study)

NCT03607838

This study is to evaluate the effectiveness of a single-dose intervertebral disc injection of SI-6603 in subjects with lumbar disc herniation (LDH)

Lumbar Disc Herniation

Seikagaku Corporation352 participantsStarted Nov 2018

Mobile, Alabama, United States • Fountain Valley, California, United States • La Jolla, California, United States +64 more locations

QTX3046 in Patients With KRAS G12D Mutations

PaTH Clinical Data Research Network (CDRN) Idiopathic Pulmonary Fibrosis (IPF) Clinician Patient Partnership Cohort

SI-6603 (Condoliase) Study for Lumbar Disc Herniation (Discovery 6603 Study)

Find Trials by Condition in Salt Lake City

Evaluating the Safety and Efficacy of Tradipitant vs. Placebo in Idiopathic and Diabetic Gastroparesis

Study Evaluating Food Effect and QTc in Patients With Advanced Malignancies

This Study Will Collect Clinical and Patient Reported Experience Data From Participants Requiring Urine Output Management Overnight in the Home Setting.

A Study to Evaluate the Safety and Efficacy of NEXAGON® (Lufepirsen Ophthalmic Gel) in Subjects With PCED

Diet and Fasting for Long COVID

Specialty Compared to Oncology Delivered Palliative Care for Patients With Acute Myeloid Leukemia

Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH)

A Study of Nivolumab and Ipilimumab in Untreated Participants With Stage 3 Non-small Cell Lung Cancer (NSCLC) That is Unable or Not Planned to be Removed by Surgery

Study of Efficacy, Safety, and Tolerability of LNA043 in Patients With Knee Osteoarthritis

A Study of LY3372689 to Assess the Safety, Tolerability, and Efficacy in Participants With Alzheimer's Disease

First-in-human Study of MRT-6160 in Healthy Subjects

Prospective, Open-label, Non-significant Risk, Multicenter Study Comparing the Polyp Detection of the Study Device to That of the Colonoscopy Reference

Open-Label Surufatinib in European Patients With NET

Trial of ARV-110 and Abiraterone in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Efficacy, Safety, and Pharmacokinetics of Sugammadex (MK-8616) for Reversal of Neuromuscular Blockade in Pediatric Participants Aged Birth to <2 Years (MK-8616-169)

A-LiNK: Improving Outcomes in Autoimmune Liver Disease

Ceribell Delirium Data Collection Study